Licensing and Analysis of the MAPLE Medical Isotope Reactors and the New Processing Facility

Candesco team members provide leadership and specialized technical expertise in developing strategy and resolving issues related to the regulatory approval for testing of the MAPLE medical isotope reactors at increasingly higher power plateaus. Candesco staff have also acted in project integration roles for the MAPLE Final Safety Analysis Report Update.